Skip to content

The Global Angelman Syndrome Registry

The Global Angelman Syndrome Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05293184
Acronym
GASR
Enrollment
5000
Registered
2022-03-24
Start date
2016-09-28
Completion date
2099-12-31
Last updated
2026-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angelman Syndrome

Keywords

Angelman Syndrome, Registries, Observational study only

Brief summary

The Global Angelman Syndrome Registry is an online patient organisation driven registry to collect information about the natural history of children and adults with Angelman Syndrome. The registry will facilitate 1) recruitment for clinical trials into therapies and interventions to benefit participants with Angelman Syndrome and their families, and 2) advancement of research and best standards of care for Angelman Syndrome. The registry is currently available in English, Spanish, Traditional Chinese, Italian, Polish, Hindi, and Brazilian Portuguese.

Interventions

Sponsors

Foundation for Angelman Syndrome Therapeutics, Australia
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Angelman Syndrome

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Gather longitudinal data on individuals living with Angelman Syndrome70 years (lifespan)Parent/ caregiver reporting on diagnosis, clinical status, and patient-reported outcomes of individual living with Angelman Syndrome. This will be achieved by inviting parents/ caregivers with additional questionnaire like modules, and tracking changes in their responses over time.

Countries

Australia

Contacts

CONTACTMegan Tones
curator@angelmanregistry.info
CONTACTNiki Armstrong
curator@angelmanregistry.info
PRINCIPAL_INVESTIGATORHelen (Honey) Heussler, MBBS, FRACP DM

The University of Queensland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 4, 2026